Cancer Vaccines as Immunotherapy of Cancer provides extensive and state-of-the-art information about the meaning, relevance and limitation of therapeutic cancer vaccines. It covers all the aspects involved in the vaccine research and development (identification of optimal target antigens, formulations, delivery strategies, adjuvants among others) as well as their use in combination with other immunomodulatory approaches.
The book discusses topics such as identification of tumor associated and specific antigens, proteogenomic for identification of novel target tumor antigens, antigen-specific T cells, and Peptide and RNA based vaccines. Additionally, it covers oncolytic viruses for antigen delivery, cancer vaccine targeting viral antigens and combinatorial immunotherapy strategies.
Written by leading experts worldwide, this is a valuable resource for cancer researchers, oncologists and members of biomedical field who wants to understand in depth the recent findings in the field of cancer vaccines.
1. Cancer Vaccines as Immunotherapy of Cancer - p. Page i 2. Cover - p. Page i 3. Title page - p. Page ii 4. Table of Contents - p. Page iii 5. Copyright - p. Page iii 6. Contents - p. Page vi 7. List of contributors - p. Page vii 8. About the editors - p. Page vii 9. Preface - p. Page viii 10. List of Illustrations - p. Page x 11. List of Tables - p. Page xi 12. Chapter 1 : Oncolytic viruses for antigen delivery - p. Page xi 13. Chapter 2 : Tumor lysates cancer vaccine - p. Page 13 14. Chapter 3 : Tumor antigens for preventative cancer vaccines - p. Page 37 15. Chapter 4 : Regulatory aspects of cancer immunotherapy in Europe - p. Page 66 16. Chapter 5 : Identification of tumor antigens for T-cell-mediated cancer immunotherapy - p. Page 83 17. Chapter 6 : Therapeutic cancer vaccines targeting viral antigens - p. Page 94 18. Chapter 7 : Novel dendritic cell vaccine strategies - p. Page 104 19. Chapter 8 : Combinatorial immunotherapy strategies for cancer vaccines - p. Page 129 20. Chapter 9 : Peptide-based vaccines - p. Page 148 21. Chapter 10 : Personalized peptide vaccines - p. Page 167 22. Chapter 11 : Antigen-specific T cells - p. Page 186 23. Chapter 12 : Adjuvants for improving cancer vaccines - p. Page 205 24. Chapter 13 : Nucleic acid-based vaccines - p. Page 221 25. Index - p. Page 241
Cancer Vaccines as Immunotherapy of Cancer provides extensive and state-of-the-art information about the meaning, relevance and limitation of therapeutic cancer vaccines. It covers all the aspects involved in the vaccine research and development (identification of optimal target antigens, formulations, delivery strategies, adjuvants among others) as well as their use in combination with other immunomodulatory approaches.
The book discusses topics such as identification of tumor associated and specific antigens, proteogenomic for identification of novel target tumor antigens, antigen-specific T cells, and Peptide and RNA based vaccines. Additionally, it covers oncolytic viruses for antigen delivery, cancer vaccine targeting viral antigens and combinatorial immunotherapy strategies.
Written by leading experts worldwide, this is a valuable resource for cancer researchers, oncologists and members of biomedical field who wants to understand in depth the recent findings in the field of cancer vaccines.
1. Cancer Vaccines as Immunotherapy of Cancer - p. Page i 2. Cover - p. Page i 3. Title page - p. Page ii 4. Table of Contents - p. Page iii 5. Copyright - p. Page iii 6. Contents - p. Page vi 7. List of contributors - p. Page vii 8. About the editors - p. Page vii 9. Preface - p. Page viii 10. List of Illustrations - p. Page x 11. List of Tables - p. Page xi 12. Chapter 1 : Oncolytic viruses for antigen delivery - p. Page xi 13. Chapter 2 : Tumor lysates cancer vaccine - p. Page 13 14. Chapter 3 : Tumor antigens for preventative cancer vaccines - p. Page 37 15. Chapter 4 : Regulatory aspects of cancer immunotherapy in Europe - p. Page 66 16. Chapter 5 : Identification of tumor antigens for T-cell-mediated cancer immunotherapy - p. Page 83 17. Chapter 6 : Therapeutic cancer vaccines targeting viral antigens - p. Page 94 18. Chapter 7 : Novel dendritic cell vaccine strategies - p. Page 104 19. Chapter 8 : Combinatorial immunotherapy strategies for cancer vaccines - p. Page 129 20. Chapter 9 : Peptide-based vaccines - p. Page 148 21. Chapter 10 : Personalized peptide vaccines - p. Page 167 22. Chapter 11 : Antigen-specific T cells - p. Page 186 23. Chapter 12 : Adjuvants for improving cancer vaccines - p. Page 205 24. Chapter 13 : Nucleic acid-based vaccines - p. Page 221 25. Index - p. Page 241
